Nicole Petersen, assistant professor in the the Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, will present “Noninvasive Neuromodulation: A New Way Forward for Addiction Medicine” at 1:30 p.m. Feb. 12 in Oldfather Hall, Room 430G. This seminar is free and open to the public; no registration is required.
Historically, addiction treatment has relied on pharmacotherapy, behavioral interventions or a combination of the two. Despite many remarkable successes, lasting reductions in and abstinence from substance use remain challenging. Noninvasive neuromodulation offers a new path forward: By directly targeting brain circuits involved in addiction, neurobiologically-informed precision treatments can be developed.
Petersen will focus on recent developments in transcranial magnetic stimulation, the first type of noninvasive neuromodulation to receive FDA clearance for a substance use indication. She will discuss developments in this technology for smoking cessation, with a focus on how different brain targets produce different clinical outcomes. Petersen will also address sex and sex hormone influences on brain circuits relevant to addiction, and how these biological factors may affect neuromodulation treatment response.
This event is co-sponsored by the Rural Drug Addiction Research Center and the Center for Brain, Biology and Behavior.
